This compound is a chiral pharmaceutical intermediate featuring a purine ring system linked to a fluorophenylsulfanylmethyl-substituted tetrahydrofuran diol. It is primarily used in the synthesis of adenosine analogs for research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(2S,3R,5R)-5-(6-Amino-2-iodo-9H-purin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide (non-preferred name)
pharmaceutical intermediate
2,2-Dimethyl-5-(3-thienyl)-1,3-dioxane-4,6-dione
pharmaceutical intermediate
Methyl (3-formyl-4-hydroxyphenyl)acetate
pharmaceutical intermediate
2-Chloro-1-(pyridin-3-yl)ethan-1-one--hydrogen chloride (1/1)
pharmaceutical intermediate
3-Amino-1,2,3,4-tetrahydrocarbazol
pharmaceutical intermediate
(2S,3S,4R,5R)-2-[(2-fluorophenyl)sulfanylmethyl]-5-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]oxolane-3,4-diol
IZRXENCTXNMAMI-DIJFLQFKSA-N
C1C[C@H]([C@@H](C1)O)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CSC5=CC=CC=C5F)O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.